GENI vs EVER

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

GENI

53.8
AI Score
VS
GENI Wins

EVER

34.6
AI Score

Investment Advisor Scores

GENI

54score
Recommendation
HOLD

EVER

35score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric GENI EVER Winner
Revenue 669.49M 692.52M EVER
Net Income -111.58M 99.31M EVER
Net Margin -16.7% 14.3% EVER
Operating Income -151.33M 58.34M EVER
ROE -15.4% 41.7% EVER
ROA -9.9% 30.4% EVER
Total Assets 1.13B 326.91M GENI
Cash 280.56M 171.38M GENI
Current Ratio 1.56 2.94 EVER

Relative Price Performance (Last 90 Days)

GENI 1M: +6.9% · 3M: +0.9% EVER 1M: +33.8% · 3M: -5.8%

Current Technical Phase

GENI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 51.1 · Price: $6.54

EVER

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 63

RSI (14): 63.0 · Price: $23.59

Fundamentals Snapshot

Metric GENI EVER
Market Cap — —
Forward P/E 6.1 7.7
Trailing P/E — 7.2
Revenue (TTM) — —
Revenue Growth 0.6% 0.2%
Gross Margin 0.3% 1.0%
Operating Margin -0.1% 0.1%
EPS -0.67 3.07
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GENI is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.